Samuel Chen, MD, PH.D.
NPI 1396803474 · Internal Medicine Physician · Houston, TX
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1396803474
- Entity type
- Individual
- Primary specialty
- Internal Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PH.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- K3125 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,038 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 840 | $122 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 727 | $9 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 283 | $14 |
| Removal of Impacted Ear Wax69210 | 75 | $46 |
| Stool Analysis for Blood to Screen for Colon Tumors82270 | 39 | $4 |
| Annual Depression Screening, 5 to 15 MinutesG0444 | 25 | $18 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 65 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Amlodipine Besylate | 218 | 68 |
| Rosuvastatin Calcium | 209 | 73 |
| Metformin Hcl | 185 | 63 |
| Atorvastatin Calcium | 153 | 49 |
| Losartan Potassium | 116 | 36 |
| Famotidine | 112 | 44 |
| Simvastatin | 111 | 35 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,010 across 25 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-12-04
- Last updated
- 2024-10-19
- Certified
- 2024-10-18
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.